ALFACELL CORP
4, 1996-07-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: SOMANETICS CORP, 10-Q, 1996-07-10
Next: ALFACELL CORP, 4, 1996-07-10




<PAGE>

FORM 4 

                                U.S. SECURITIES AND EXCHANGE COMMISSION
                                       WASHINGTON, D.C. 20549
                     STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
<square>Check this box if no longer
   subject to Section 16. Form 4    Filed pursuant to Section 16(a) of the
or Form 5 obligations           Securities Act of 1934, Section 17(a)
                                 of the Public Utility Holding Company Act 
                              of 1935 or Section 30(f) of the Investment
                                           Company Act of 1940
may continue.  SEE Instruction 1(b).


<TABLE>
<CAPTION>
1. Name and Address of Reporting Person        2. Issuer Name and Ticker or Trading Symbol   6.  Relationship of Reporting Person
                                                                                             to Issuer
SHOGEN,      KUSLIMA                           ALFACELL CORPORATION (ACEL)             (Check all applicable)
                                                                                                ___X____ Director______ 10% Owner
<S>                                            <C>        <C>   <C> <C>      <C>    <C>      <C>            <C>         <C>
(Last)              (First)           (Middle) 3. IRS or Social     4. Statement for            ___X____ Officer     ______ Other
                                               Security Number of      Month/Year               (give title below)
C/O ALFACELL CORPORATION, 225 BELLEVILLE       Reporting Person                              (specify below)
AVENUE                                         (Voluntary)                 JUNE 1996
                                                                                             PRESIDENT AND CHIEF EXECUTIVE OFFICER
                   (Street)                                         5. If Amendment,
                                                                       Date of Original
BLOOMFIELD, NEW  JERSEY        07003                                     (Month/Year)
(City)              (State)              (Zip)
                                               TABLE I - NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
1. Title of Security                           2. Trans-  3. Trans- 4. Securities Acquired   5. Amount of   6. Owner-   7. Nature
   (Instr. 3)                                     action     action    (A) or Disposed of       Securities     ship        of In-
                                                  Date       Code      (D)                      Beneficially   Form:       direct
                                                  (Month/  (Instr.     (Instr. 3, 4 and 5)      Owned at       (D) or      Bene-
                                               Day/       8)                                    End of         Indirect    ficial
                                               Year)                                            Month          (I)         Owner-
                                                                                                (Instr. 3      (Instr.     ship
                                                                                             and 4)         4)             (Instr.
                                                                                                                        4)
                                                          Code   V   Amount  (A) or Price
                                                                               (D)

Common Stock                                    6/14/96   S         12,500     D     $5.63     1,059,000         D         ----

                                                                                                 284,000          I       By Trust









</TABLE>

Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
                                               (Over)













<PAGE>

FORM 4 (CONTINUED)


                 TABLE II - DERIVATIVE SECURITIES ACQUIRED,
                 DISPOSED OF, OR BENEFICIALLY OWNED
 (E.G., puts, calls, warrants, options, convertible securities)

<TABLE>
<CAPTION>
1. Title of Derivative   2.Conver3.Trans-4.Transac-5.Number of6.Date   7.Title and Amount of 8.Price9.Number10.        11.  Na-
Security                   sion   action tion  Deriv-       ExercisableUnderlying Securities   of    of       Owner-     ture
   (Instru. 3)             or     Date   Code  ative        and        (Instr. 3 and 4)        Deriv-Deriv-   ship        of In-
                           Exercise(Month/Day/(Instr.SecuritiesExpiration                      ative ative     Form       direct
                           Price  Year)8)      Ac-          Date                               Secur-Secur-    of De-     Bene-
                           of                  quired (A)   (Month/Day/                        ity   ities                ficial
                           Deriv-              or           Year)                              (Instr.Bene-   rivative    Own-
                           ative               Disposed                                        5)    ficially  Secu-       ership
                         Security              of (D)                                                Owned     ity:      (Instr. 4)
                                               (Instr. 3,                                            at End    (D) or
                                             4, and 5)                                               of        Indi-
                                                                                                     Month     rect
                                                                                                     (Instr.  (I)
                                                                                                     4)        (Instr.
                                                                                                               4)
<S>                  <C>    <C>    <C> <C>  <C> <C>   <C>     <C>    <C>                <C>    <C>   <C>      <C>      <C>
                                  Code  V   (A) (D)   Date   Expira-     Title        Amount
                                                       Exer-  tion                   or
                                                      cisable Date                   Number
                                                                                     of
                                                                                     Shares

Stock Option      $3.87    6/14/96   X        12,500  9/16/92 9/16/96   Common     12,500   $3.87   487,500    D       --
(right to buy)                                                            Stock        








</TABLE>

  Explanation of Responses:





** Intentional misstatements or omissions of facts constitute Federal Criminal
   Violations.
                          /S/KEVIN T. COLLINS                     7/10/96
   SEE 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
                          **Signature of Reporting Person           Date
                          Kevin T. Collins, as Attorney-in-fact
Note:  File three copies of this Form, one of which must be manually signed.
   If space provided is insufficient, SEE Instruction 6 for procedure.
                                                      SEC 1474 (8-92)


















© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission